Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blase Polite

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Women'S Health (2002)|February 26, 2020
Gender- and Race-Based Differences in Barriers and Facilitators to Early Detection of Colon CancerKatherine C Brewer, Nadine R Peacock, Carol E Ferrans, et al.
Clinical Colorectal Cancer|January 7, 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinomaAllyson J Ocean, Blase Polite, Paul Christos, et al.
Journal of Surgical Oncology|January 13, 2023
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastasesRyan B Morgan, Ankit Dhiman, Divya Sood, et al.
JCO Oncology Practice|May 5, 2026
340B Drug Pricing Program: An Updated ASCO Policy StatementBlase Polite, Niharika Dixit, John Hennessy, et al.
American Journal of Clinical Oncology|December 3, 2021
Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal DisseminationMason Vierra, Ankit Dhiman, Hunter D D Witmer, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
JCO Oncology Practice|October 17, 2022
Evaluating the Addition of Clinical and Staging Data to Improve the Pricing Methodology of the Oncology Care ModelTheresa R F Dreyer, Emily Hamilton, Alyssa Dahl, et al.
Annals of Surgery|March 30, 2023
Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent SurgeryAnkit Dhiman, Vishesh Kothary, Hunter D D Witmer, et al.
American Journal of Surgery|October 6, 2023
Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastasesFrances T Lee, Jelani Williams, Rachel Nordgren, et al.
Journal of Surgical Oncology|October 19, 2017
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot studyRobert de W Marsh, Mark S Talamonti, Marshall S Baker, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Women'S Health (2002)|February 26, 2020
Gender- and Race-Based Differences in Barriers and Facilitators to Early Detection of Colon CancerKatherine C Brewer, Nadine R Peacock, Carol E Ferrans, et al.
Clinical Colorectal Cancer|January 7, 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinomaAllyson J Ocean, Blase Polite, Paul Christos, et al.
Journal of Surgical Oncology|January 13, 2023
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastasesRyan B Morgan, Ankit Dhiman, Divya Sood, et al.
JCO Oncology Practice|May 5, 2026
340B Drug Pricing Program: An Updated ASCO Policy StatementBlase Polite, Niharika Dixit, John Hennessy, et al.
American Journal of Clinical Oncology|December 3, 2021
Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal DisseminationMason Vierra, Ankit Dhiman, Hunter D D Witmer, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|August 28, 2019
Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment SettingCasey Mason, Peter G Ellis, Kathy Lokay, et al.
JCO Oncology Practice|October 17, 2022
Evaluating the Addition of Clinical and Staging Data to Improve the Pricing Methodology of the Oncology Care ModelTheresa R F Dreyer, Emily Hamilton, Alyssa Dahl, et al.
Annals of Surgery|March 30, 2023
Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients With Peritoneal Metastases From Colorectal and High-grade Appendix Cancer Undergoing Curative-intent SurgeryAnkit Dhiman, Vishesh Kothary, Hunter D D Witmer, et al.
American Journal of Surgery|October 6, 2023
Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastasesFrances T Lee, Jelani Williams, Rachel Nordgren, et al.
Journal of Surgical Oncology|October 19, 2017
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot studyRobert de W Marsh, Mark S Talamonti, Marshall S Baker, et al.
Pageof 5